ArticleMikrochimica acta2023
Electrochemically deposited bimetallic SERS substrate for trace sensing of antibiotics.
Article in Mikrochimica acta, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Early Screening for Cervical Squamous Cell Carcinoma and Precancerous Lesions Based on Surface-Enhanced Raman Spectroscopy Microarray Chips.International journal of nanomedicine · 2026Article
- Sensitive and Stable NCF/GO/Au@Ag SERS Substrate for Trace Detection of Polycyclic Aromatic Hydrocarbons.Polymers · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Electrochemically deposited bimetallic copper-gold nanoparticles on indium tin oxide (Cu-AuNPs on ITO) glass are demonstrated to be a sensitive and reproducible surface-enhanced Raman scattering (SERS) platform. An optimal signal enhancement with reasonably good degree of homogeneity was obtained by tuning the deposition parameters of the electrochemical setup. For Raman active analytes such as malachite green (MG) and rhodamine 6G (R6G), the developed SERS platform yields a limit of detection (LOD) of 0.75 nM. The usability of the proposed SERS platform has been realized through detection of two important antibiotics namely sulfamethoxazole (SFZ) and tetracycline hydrochloride (TCH) commonly used in egg farms. Furthermore, a machine learning (ML)-based model coupled with a dimensionality reduction technique-principal component analysis (PCA)-has been implemented to classify the targeted analytes in egg samples.
Indexed as
Identifiers
38087069What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.